Ranitidine Syrup
Product Images NDC 0121-0727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 0121-0727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaceutical Associates, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ranitidine 01)

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Principal Display Panel (473 mL Bottle Label)
This is a description of Ranitidine Syrup, an oral solution used for treatment. It contains 15mg/mL (75mg/5mL) of ranitidine hydrochloride and is alcohol-free. Each 1mL contains 16.8mg of ranitidine. It is a USP controlled room temperature product. Store at 20° to 25°C (68° to 77°F) and do not freeze. Please refer to the attached package insert for complete dosage recommendations. Dispense in tight, light-resistant containers.*
FDA Label Image

Principal Display Panel (10 mL Cup Lid)

Principal Display Panel (10 mL Cup Lid)
This product is Ranitidine Syrup, an oral solution used to treat stomach and intestinal ulcers, gastroesophageal reflux disease, and conditions that cause the stomach to produce too much acid. Each 10 mL dose contains 150 mg of ranitidine hydrochloride. The solution should be stored at room temperature and not frozen. The prescribed dosage should be followed according to the instructions in the package insert. This product is intended for institutional use only and requires a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.